Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Ibuprofen and Acetaminophen Suspension
NCT05428293Phase 1Completed
- Sponsor
- Laboratorios Silanes
- Start
- Feb 2019
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in pain and fever comparing Ibuprofen/Acetaminophen Combo, Ibuprofen Monotherapy and Acetaminophen Monotherapy (3 arms). Primary endpoints: Maximum observed concentration at 14 hours and Area under the curve from time zero to last measurable concentration at 14 hours. Started Feb 2019; status: completed.
02
Drugs
ibuprofenacetaminophen
03
Conditions
painfever
Beyond the preview
Go deeper on NCT05428293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05428293.